Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition

Cervix Cancer Clinical Trial

Official title:

Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00571415
• Other study ID #: HM10390
• Secondary ID: P01CA116602
• Status: Terminated
• Phase: N/A
• First received: December 11, 2007
• Last updated: May 27, 2016
• Start date: March 2009
• Est. completion date: October 2015

Study information

• Verified date: May 2016
• Source: Virginia Commonwealth University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Within this study patient data are collected from different imaging and motion monitoring devices that will be used to develop and test strategies for image-guided adaptive radiotherapy in cervix cancer patients.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 21
• Est. completion date: October 2015
• Est. primary completion date: May 2013
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Histological diagnosis of cervix cancer

• Prescription of radiation treatment to the primary cancer

Exclusion Criteria:

• Prior radiation treatment to the pelvis

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cervix Cancer
• Uterine Cervical Neoplasms

Locations

Country	Name	City	State
United States	Viriginia Commonwealth University, Department of Radiation Oncology	Richmond	Virginia

Sponsors (2)

Lead Sponsor	Collaborator
Virginia Commonwealth University	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Increase in therapeutic ratio		5 years	No